|
answer text |
<p>Research and Development (R&D) tax reliefs, including the small or medium-sized
enterprise (SME) scheme, support businesses to invest and are a core part of the Government’s
support for innovation.</p><p> </p><p>Budget 2018 announced a cap on the payable tax
credit element of the SME tax relief scheme of three times the company’s total PAYE
and NICs liability for that year, to help prevent identified fraud and abuse of the
scheme.</p><p> </p><p>The Government consulted between 28 March and 24 May 2019 on
how the cap will be applied so as to minimise any impact on genuine businesses. The
responses to that consultation, including those from representatives in the life sciences
sector, are being analysed.</p>
|
|